Shilpa Gupta, Director of Genitourinary Oncology at the Cleveland Clinic, shared on X/Twitter:
“We report for the 1st time the role of tumor fraction in ctDNA in patients with metastatic urothelial cancer in real world.
- association with clinico-pathologic features and real world PFS
- prognostic biomarker
- may help personalize treatment
- prospective trials needed.”
View additional information.
Source: Shilpa Gupta/X
